Skip to Content Facebook Feature Image

Footballer Isco Alarcón Signs With Skechers

News

Footballer Isco Alarcón Signs With Skechers
News

News

Footballer Isco Alarcón Signs With Skechers

2025-02-20 16:00 Last Updated At:16:20

MADRID--(BUSINESS WIRE)--Feb 20, 2025--

Skechers Football brings champion strength to the pitch in Spain with the signing of Isco Alarcón, the celebrated midfielder from Real Betis Balompié. Well known for his ball skills, Alarcón is already competing in the Skechers Razor 1.5 Elite —the lightweight speed boot for players who want amazing fit, feel, and touch on the pitch. Alarcón will appear in marketing campaigns supporting Skechers Football.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250214818876/en/

Real Betis Balompié midfielder Isco Alarcón signs with Skechers and now competes in Skechers Razor 1.5 Elite boots. (Photo: Business Wire)

“Football and life are played better when you feel comfortable at every step,” said Isco. “I’m very excited to be part of the Skechers family in this next chapter in my career.”

“Isco Alarcón is a great football player with a significant track record at the national level. He’s returning from an injury to his elite-level play, which is the perfect time to officially bring him onto Team Skechers,” added Txerra Díaz, Country Manager of Skechers Iberia. “We believe he fully aligns with the brand’s profile and will help players across Spain and Portugal discover Skechers Football and the signature Comfort That Performs offered by our boots.”

Francisco Román Alarcón Suárez (Benalmádena, Málaga, April 21, 1992) is a world-renowned attacking midfielder, thanks to his outstanding performances in the Spanish League and various international competitions. He has played for Valencia CF, Málaga CF and Real Madrid, with whom he won five UEFA Champions League titles, before joining Real Betis Balompié. His exquisite technique, tactical intelligence and ability to make a difference on the field have established him as one of the great midfielders of his generation.

Alarcon adds his superstar power to the roster of talented athletes currently competing in Skechers Football boots in Spain, including Iker Losada from the Celta, Antonio Sánchez from Real Mallorca, and Pere Milla from Espanyol, among others.

The Skechers Football range spans three Elite styles for men and women including the new Electrum Pack. The Skechers Razor is a lightweight speed boot with an explosive track-inspired design to maximize acceleration and energy return. It features a carbon-infused soleplate for responsive power and agility during play. The SKX_01 is ideal for striking the ball with a custom last meticulously crafted to optimize comfort and deliver a perfect fit for enhancing touch on the field. Both boots are available in standard low-profile with the SKX_01 also available in a high-top version.

In addition to the Elite styles, Skechers also offers a line of Academy boots perfect for all levels of play with maximized performance and comfort, as well as Youth and Kids boots for the next generation of players who want to emulate their favorite stars, featuring an adaptable fit and enhanced comfort in every pair. Both ranges are available in firm ground and turf styles.

Skechers Football launched at the start of the 2023/24 season when the brand signed Bayern Munich striker Harry Kane as the first pro to compete in the boot. Skechers has since expanded its roster with several elite athletes including winger Baris Alper Yilmaz from the Turkey National Team, West Ham United and Ghana National Team winger Mohammed Kudus, Arsenal and Ukrainian National Team defender Oleksandr Zinchenko, Nottingham Forest and Swedish National Team forward Anthony Elanga, as well as additional men’s and women’s professional athletes globally.

Beyond football, the Skechers team of elite athletes competing in the brand’s performance footwear includes basketball stars Joel Embiid, Julius Randle, Terance Mann, Josh Green, and Rickea Jackson; golfers Matt Fitzpatrick and Brooke Henderson; pickleball pros Tyson McGuffin and Catherine Parenteau; and Major League Baseball players Clayton Kershaw and Aaron Nola, among others.

The Skechers Football collection is available at Skechers websites, select Skechers retail stores, as well as specialty football retailers worldwide such as Fútbol Emotion in Spain. Football fans can get behind-the-scenes access to Skechers Football product launches and more by following @skechersfootball on Instagram and TikTok.

About Skechers USA Iberia, S.L. and SKECHERS U.S.A., Inc.

Skechers USA Iberia, S.L. is a subsidiary of Skechers U.S.A., Inc. (NYSE:SKX), The Comfort Technology Company ® based in Southern California. Skechers designs, develops, and markets a diverse range of lifestyle and performance footwear, apparel, and accessories for men, women, and children. The Company’s collections are available in 180 countries and territories through department and specialty stores and direct to consumers through skechers.com and approximately 5,300 Skechers retail stores. A Fortune 500 ® company, Skechers manages its international business through a network of wholly-owned subsidiaries, joint venture partners, and distributors. For more information, please visit about.skechers.com and follow us on Facebook, Instagram, X, and YouTube.

This announcement contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may include, without limitation, Skechers’ future domestic and international growth, financial results, and operations including expected net sales and earnings, its development of new products, future demand for its products, its planned domestic and international expansion, the opening of new stores and additional expenditures, and advertising and marketing initiatives. Forward-looking statements can be identified by the use of forward-looking language such as “believe,” “anticipate,” “expect,” “estimate,” “intend,” “plan,” “project,” “will,” “could,” “may,” “might,” or any variations of such words with similar meanings. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in forward-looking statements. Factors that might cause or contribute to such differences include the disruption of business and operations due to the COVID-19 pandemic; delays or disruptions in our supply chain; international economic, political and market conditions including the effects of inflation and foreign currency exchange rate fluctuations around the world, the challenging consumer retail markets in the United States, and the impact of wars, acts of war and other conflicts around the world; sustaining, managing and forecasting costs and proper inventory levels; losing any significant customers; decreased demand by industry retailers and cancellation of order commitments due to the lack of popularity of particular designs and/or categories of products; maintaining brand image and intense competition among sellers of footwear for consumers, especially in the highly competitive performance footwear market; anticipating, identifying, interpreting or forecasting changes in fashion trends, consumer demand for the products and the various market factors described above; sales levels during the spring, back-to-school and holiday selling seasons; and other factors referenced or incorporated by reference in Skechers’ annual report on Form 10-K for the year ended December 31, 2023 and its quarterly reports on Form 10-Q in 2024. Taking these and other risk factors associated with the COVID-19 pandemic into consideration, the dynamic nature of these circumstances means that what is stated in this press release could change at any time, and as a result, actual results could differ materially from those contemplated by such forward-looking statements. The risks included here are not exhaustive. Skechers operates in a very competitive and rapidly changing environment. New risks emerge from time to time, and we cannot predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, you should not place undue reliance on forward-looking statements as a prediction of actual results. Moreover, reported results should not be considered an indication of future performance.

Skechers Football releases the new Electrum Pack, now available with the SKX_01 and Skechers Razor boots. (Photo: Business Wire)

Skechers Football releases the new Electrum Pack, now available with the SKX_01 and Skechers Razor boots. (Photo: Business Wire)

SAN FRANCISCO & JACKSONVILLE, Fla.--(BUSINESS WIRE)--Jan 12, 2026--

Abridge, the leading enterprise-grade AI for clinical conversations, is collaborating with Availity, the nation’s largest real-time health information network, to launch a first-of-its kind prior authorization experience. The engagement uses cutting-edge technology grounded in the clinician-patient conversation to facilitate a more efficient process between clinicians and health plans in medical necessity review.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112960386/en/

Rather than creating parallel AI systems across healthcare stakeholders, Abridge and Availity are working together to ensure shared clinical context at the point of conversation powers administrative processes, such as prior authorization review and submission, improving outcomes for patients and the teams delivering care.

This collaboration unites two trusted and scaled organizations: combining Abridge’s enterprise-grade AI platform, serving over 200 health systems and projected to support over 80 million patient-clinician conversations in 2026, with Availity’s next-generation, FHIR-native Intelligent Utilization Management solution, which helps payers and providers digitize and operationalize coverage requirements within administrative workflows.

Availity’s FHIR-native APIs enable fast, scalable, and secure connectivity of payer information across the entire healthcare ecosystem. With Abridge’s Contextual Reasoning Engine technology, clinicians can gain visibility into relevant clinical information during the conversation to support documentation aligned with prior authorization requirements.

“At Availity, we’ve invested in building AI-powered, FHIR-native APIs designed to bring clinical policy logic directly into provider workflows,” said Russ Thomas, CEO of Availity. “By embedding our technology at the point of conversation, we’re enabling faster, more transparent utilization management decisions rooted in clinical context. We’re excited to collaborate with Abridge and to demonstrate what’s possible when payer intelligence meets real-time provider workflows.”

The development of real-time prior authorization is just a component of a broader revenue cycle collaboration that is focused on applying real-time conversational intelligence across the patient, provider, and payer experiences. The companies intend to support integration by collaborating on workflow alignment between their respective platforms in the following areas:

“Abridge and Availity are each bringing national scale, deep trust, and a track record of solving important challenges across the care and claims experience to this partnership,” said Dr. Shiv Rao, CEO and Co-Founder of Abridge. “We’re building real-time bridges between patients, providers, and payers, unlocking shared understanding, focused at the point of conversation.”

About Availity

Availity empowers payers and providers to deliver transformative patient experiences by enabling the seamless exchange of clinical, administrative, and financial information. As the nation's largest real-time health information network, Availity develops intelligent, automated, and interoperable solutions that foster collaboration and shared value across the healthcare ecosystem. With connections to over 95% of payers, more than 3 million providers, and over 2,000 trading partners, Availity provides mission-critical connectivity to drive the future of healthcare innovation. For more information, including an online demonstration, please visit www.availity.com or call 1.800.AVAILITY (282.4548). Follow us on LinkedIn.

About Abridge

Abridge was founded in 2018 to power deeper understanding in healthcare. Abridge is now trusted by more than 200 of the largest and most complex health systems in the U.S. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experience. With deep EHR integration, support for 28+ languages, and 50+ specialties, Abridge is used across a wide range of care settings, including outpatient, emergency department, and inpatient.

Abridge’s enterprise-grade AI platform is purpose-built for healthcare. Supported by Linked Evidence, Abridge is the only solution that maps AI-generated summaries to source data, helping clinicians quickly trust and verify the output. As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for the responsible deployment of AI across health systems.

Abridge was awarded Best in KLAS 2025 for Ambient AI in addition to other accolades, including Forbes 2025 AI 50 List, TIME Best Inventions of 2024, and Fortune’s 2024 AI 50 Innovators.

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation

Recommended Articles